• The overall penetration rate of asset finance in global medical equipment sales over this period has grown annually by an average of nearly 7%
• No respondent reported any decline in the demand for healthcare equipment finance over the last two years. Respondents either reported growth or no change
• Looking to the future, over 60% of respondents believe that the proportion of their sales financed through asset finance will continue to rise steadily over the next two years, by an estimated average of more than 3% per annum
• This increasing penetration rate for medical equipment finance should be viewed in combination with projected annual growth rates for the medical device market of around 7% per annum 1 -meaning the overall growth in the adoption of asset finance is approaching levels of 10%
• Although the last two years saw a broadly consistent rise in medical equipment finance demand from public and private sector healthcare organizations, the growth in the next two years is expected to be stronger in private healthcare institutions
• 64% of respondents report that healthcare organizations globally are feeling a squeeze on their capital budgets
• 57% report an increase in demand from healthcare organizations for tailored financing to acquire new equipment, reflecting how these organization are turning to asset finance to overcome these capital budget pressures
• And in a related finding, 64% of respondents observe that their customers are increasingly using the concept of Total Cost of Ownership in their business case justifications for equipment acquisition, showing a recognition that other costs (service, maintenance, failure disruption, energy consumption) should also be considered in determining whether to retain or replace older equipment
Introduction
Healthcare systems across the world continue to labor under financial pressures. In mature healthcare systems, healthcare delivery is coming under strain as demand rises, whether as a result of aging populations or emerging conditions relating to trends such as increasing levels of obesity (leading to the growing diabetes crisis). In developing healthcare systems, rapid infrastructural growth has led to massive capital demands, as countries strive to make basic healthcare services (and therefore improved health outcomes) more available to the population. These countries are also experiencing growing demands on the healthcare system from increasingly affluent citizens who have become more demanding and are developing previously less common conditions as a result of the changes in lifestyle and diet that come along with their increasing affluence.
One single theme links healthcare delivery in every country in the world and that is the requirement for sustainable financing. Mature economies are struggling to bring the escalating cost of healthcare under control, and are under pressure to introduce significantly greater efficiency into the provision of healthcare. Having observed the escalation in healthcare costs experienced in the West, developing economies are determined to ensure that their growth will not falter and overheat. They are therefore keeping a very keen eye on the levels of debt taken on by healthcare organizations in their countries. 2 However, a dichotomy exists over medical technology. It is widely acknowledged that up-to-date medical technology enables better health outcomes, reduces the need for expensive invasive surgery, and improves overall diagnostic and clinical efficiency and throughput. Nevertheless, there is a cost to replacing outdated equipment, and devoting capital to such investments can be difficult to justify at a time when frontline services are under pressure to deliver efficiency. Many healthcare institutions have decided the answer is to harness private sector capital, in order to 'pay to use' their equipment, rather than tie up their own scarce funds in depreciating assets. In some technology categories, it also makes little sense to write down an equipment investment over ten years when a significant technology upgrade is likely to come along in the next three to five years.
This paper first describes new research amongst the top 40 global healthcare equipment manufacturers, specifically concerning their views on the role of asset finance in the last two years, and their predictions for the next two years. It then briefly reviews the different performance, development and financial pressures on the healthcare systems in ten countries around the world: China, France, Germany, India, Poland, Russia, Spain, Turkey, the UK and the US. Finally, in the light of these findings, the paper summarizes the size of the financial challenge, the role/benefits of asset finance and the important support that it is giving to affordable high quality healthcare around the globe.
The Role Asset Finance is Playing in Medical Equipment Acquisition
In order to understand global trends in medical equipment financing, Siemens Financial Services (SFS) commissioned research amongst the world's top 40 medical equipment manufacturers -a cohort that represents around 75% of the global medical device market. 3 In each respondent company, multiple interviewees held responsibility either for a region of the world (e.g. the Americas; Europe; etc) or had a global remit.
Asset Finance -Growth, Stability or Decline?
The research quizzed respondents on the recent trends in demand for asset finance from healthcare organizations worldwide, their future projections for this demand, and the country differences in demand for asset finance and its main drivers.
The resulting statistics reveal that:
• 68% of respondents observe that demand for healthcare equipment finance has grown in the last two years
• No respondent reported any decline in the demand for healthcare equipment finance over the last two years. In other words, all respondents either reported growth in finance penetration or no significant change
• The proportion of medical equipment sales financed through an asset finance plan has averaged a 6.9% annual growth over this period
• Looking to the future, 61% of respondents believe that this demand will continue to rise steadily over the next two years, although the penetration of medical equipment finance is expected to grow at a somewhat slower pace (3.1%) 4
• Although the last two years saw a broadly consistent rise in demand for asset finance from public and private sector healthcare organizations, the next two years are expected to see continued growth in demand from the public sector but substantially higher growth in demand from private healthcare institutions
Overall, it is clear from these research findings that asset finance is playing a key and/or an increasingly important role in medical equipment financing. The proportion of medical equipment sales financed through asset finance is either growing, or holding steady, amongst the top manufacturers -a robust indicator of swelling demand for this kind of finance. It would appear that the demand for asset finance has been heightened in the last few years, either as a result of low economic activity in mature economies, or the pressure for capital resources in economies that are rapidly building their healthcare infrastructure. While both of those different kinds of financial pressure may retrench slightly (as western economies recover and as emerging economy growth decelerates), the picture from medical equipment manufacturers is of an expanding use of asset finance, albeit at a slightly slower pace than in recent years.
Where is the Growth Coming From?
Respondents were also asked to nominate the areas of the world where the strongest acceleration in the take-up of medical equipment finance was likely to come from. They were asked to answer this question both in terms of percentage growth, but also in terms of financial volumes.
This method of questioning was designed to eliminate strong growth from the smaller asset finance markets.
Clear consensus was seen from respondents' answers, irrespective of individual responsibility for geographical region(s) of the world. Respondents noted that, over the next two to three years, particularly strong demand is expected to come from:
• Tier 1 and 2 hospitals in China 5
• Russian and Indian private sector hospitals and clinics
• Eastern Europe
• The Middle East and Turkey
• South America (all countries)
• Highly pressurized healthcare organizations in Southern Europe
Affording High Specification Equipment
According to the majority of respondents, clinicians and finance directors contemplating technology investments in mature economies are feeling pressurized to consider the compromise of acquiring equipment that is 'ok for what we need' rather than always 'absolutely top specification'. On the other hand, an overall majority of respondents also emphasized how many of their customers were using asset finance to harness private sector capital, escape from the strait-jacket of limited capital budgets, spread the cost of investment, and thereby still be able to offer improved patients services (quality of care and speed of response) based on higher specification equipment. In other words, asset finance is being viewed by many healthcare organizations as a means to harness the technology they need for the best and most efficient patient outcomes.
Another common observation from respondents was a change in mindset amongst all healthcare institutions across the world (public and private) -moving from the idea of 'owning' medical equipment more towards the notion of 'cost to use' that equipment. In fact, the expression 'cost to use' appears, at least from this research sample, to be in increasingly common usage. This financially sophisticated outlook may be connected to the fact that some respondents noted a gradual shift in investment decisions away from clinicians to finance professionals (e.g. CFOs), except where technological 5 The Chinese healthcare system is categorized into three tiers. Tier 1 hospitals have fewer than 100 beds, providing basis medical services to their own community. Tier 2 hospitals have between 100 to 500 beds, serving their city and nearby communities. Tier 3 hospitals are very large hospitals with more than 500 beds and are located in major cities. They are the most sophisticated hospitals and are the centers of medical education and research. These bestequipped hospitals provide a high level of medical care and serve patients locally and from distant areas.
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advances make such a difference in performance as to offer major performance (diagnostic/clinical outcomes), productivity or safety increments.
Being able to offer clinical services based on correctly specified, up-to-date equipment and technology is critical. Firstly, from a health outcomes point of view, not having access to up-to-date medical equipment is detrimental to patients, clinicians and hospital managers alike. Apart from the size of medical technology inventories, it is widely attested that equipment age and sophistication are also important because ultimately these factors underpin the quality of services 6 and drive improved patient care. Newer, more sophisticated medical technologies can allow for shorter examination or operation times, higher quality output, and can provide the ability to offer additional services. New procedures are in general less invasive and pose less risk for patients. Diagnosis and therapy are more effective and accurate. Modern computed tomography (CT), magnetic resonance imaging (MRI), position emission tomography (PET)-nuclear medicine and angiography medical diagnostic imaging technologies improve the quality of healthcare services and offer many possibilities for rationalization.
From an organizational point of view, having the right equipment specification is also critical. In the private medical sector, healthcare organizations compete for patients and, within certain travelling distance limitations, technology capability is one of the key factors with which to attract patients and the income they bring with them. This consideration is also increasingly pertinent in the public healthcare arena. While reimbursement levels are set by the state, patient choice about where they are treated, with funds following the patient, is already a hallmark of public healthcare provision in France and Germany. This is also becoming a reality in other health systems such as the UK and Poland. Therefore, technological capabilities in these largely public healthcare systems are an increasingly important factor in attracting patients and reimbursement income.
Total Cost of Ownership
Another key factor noted by respondents on the subject of failing to upgrade medical equipment lies in the notion of Total Cost of Ownership (TCO). This approach recognizes that capital outlay is only a fraction of total operating expenses for technology. TCO also takes into accounts administration, maintenance, service, outages (time lost when the equipment fails) and user training etc. A number of sources note that TCO can be many times the initial capital cost of a piece of equipment 7 and that older equipment tends to carry greatly inflated service and maintenance costs. 8 Effective management of total cost of use in practice, especially where equipment service and maintenance are bundled into a fixed monthly charge for the financing period, was identified by most respondents as a major advantage of asset finance for medical equipment acquisition. Hence the research finding that almost two thirds of respondents are seeing an increased focus on Total Cost of Ownership from clients across the world.
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Types of Financing Arrangement
According to the research respondents, asset finance solutions tend to be of two types:
(1) where there are no significant consumable costs, then more standard leasing packages are used;
(2) where relatively costly consumables and soft costs are involved, the finance payments tend to bundle the components, sometimes taking into account the expected volumes/patient throughput.
As the cohort of finance professionals in the healthcare sector grows, respondents noted that asset finance propositions are becoming more and more competitive and flexible. At a basic level, pricing of finance has to be demonstrably competitive and is coming in for increasing scrutiny (seen in the context of local prime commercial loan rates -e.g. 18.5% in Turkey and 9.3% in Russia). Of equal importance is the flexibility of plan and specialist tailoring for the healthcare market requirements that financiers can offer, with 57% of respondents noting increasing interest from the healthcare sector in tailored financing packages.
Demand is increasing for:
• combinations of equipment, consumables, software and service;
• set-up period tailored finance (grace periods);
• financing end-to-end clinical or diagnostic processes;
• refinancing deals; and
• rapid finance arrangements to meet tactical favorable taxation opportunities.
The fact that most respondents highlighted take-up of tailored, end-to-end asset financing plans may reflect a growing recognition of the need to address medical technology on the basis of TCO, rather than simply the acquisition cost of a stand-alone piece of equipment.
Such tailored, all-encompassing financing packages tend to favor -according to the survey respondents -the services of specialist financiers (often the financing division of technology firms) who have an in-depth understanding of the assets being financed and how they will be applied to improve and develop a healthcare institution's services and productivity. This allows these specialist financiers to offer flexible repayment terms without increasing risk.
Financing Challenges in Healthcare in Ten Countries across the World
While the research findings described before are applicable to all countries studied in this report, the financial pressures differ in type from country to country. This section briefly reviews the healthcare system in the following ten countries -China, France, Germany, India, Poland, Russia, Spain, Turkey, the UK, and the US. Each healthcare system is described in relation to its individual financial challenges. However, the semi-marketization reform has left China's public hospitals with serious financial challenges. 10 The authorities, while hugely committed to the goal of universal access to affordable healthcare, is equally keen not to let the rapidly developing system overheat, either in terms of healthcare standards, or in terms of over-leverage.
CHINA:
As healthcare coverage has broadened, the share of patient spending has also declined dramatically. The NRCMS pays for 75% of in-patients' costs once they are admitted to hospital and the BMIUR covers 70% of costs. 11 Yet challenges remain daunting. Even with a proportionately high level of reimbursement, patients suffering critical illnesses may still not be able to afford the difference.
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Keqiang emphasized the importance of establishing a critical illness coverage system. "There are 3 million people every year who can't afford to pay for the bills when diagnosed with critical conditions despite the reimbursement," he pointed out. 12 Interestingly, the Chinese authorities see a significant role for the private sector in healthcare developments. At the 18th National Congress of the Communist Party of China (CPC), China renewed its health policies and for the first time the congress report explicitly stated, "We should encourage the development of private hospitals." 13 So, from a financing perspective, in an atmosphere of rapid development where there are concerns about attracting sufficient volumes of trained clinicians and care professionals, asset finance solutions are providing Chinese hospitals and clinics with an important financing technique that frees liquidity for immediate tactical needs, and efficiently aligns the cost to use of medical equipment with the benefits the institution (and its patients) are gaining from that technology.
FRANCE:
The EU has recently said that France, which last year was given two extra years to bring its budget deficit below the EU ceiling of 3% of GDP, was "projected to miss both headline deficit and structural adjustment targets over the entire forecast period." 14 Nevertheless, progress is being made on the running deficit in the healthcare system. Cost control is a key issue, as the health insurance scheme has faced large deficits over the past 20 years. More recently, however, the health insurance scheme's deficit has fallen, from an annual €10 billion to €12 billion (US$13. In short, rationalization pressures, when combined with a desire to invest in higher levels per capita for certain medical technologies, means that French institutions and private clinics need to access efficient financing tools, such as asset finance techniques, so that precious funds are not tied up in outright purchases.
GERMANY:
The German healthcare system is recognized worldwide as providing good quality care, short waiting lists and attentive service. 19 Yet demographic change is forcing the German government to deal with escalating demand for health services in a country where the average age is 45 (the oldest population in Europe). There are currently a record 2.5 million elderly Germans in need of special care and too few healthcare personnel to take care of them. There is substantial demand for high-quality and specialty healthcare services in larger cities. 26 To encourage the private sector to establish hospitals in these cities, the government has relaxed the taxes on these hospitals for the first five years.
Private sector growth is strong, but frequently hits a financing ceiling as facilities are developed and expanded. Alongside equity and debt finance, this is where asset financing techniques offer most value in the Indian context, providing another alternative equipment financing (or sometimes refinancing) channel, especially from financiers who really understand how the technology is applied, and can therefore design and flex financing arrangements while at the same time mitigating risk through that same technological expertise.
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POLAND: Poland shares with a group of other OECD countries the following characteristics related to its healthcare system: a heavily regulated public system in which the budget constraint is stringent; significant provider choice for patients; restricted sub-national government autonomy and thin private insurance markets. 27 In addition, private financing is mainly in the form of out-of-pocket expenses covering pharmaceuticals and specialist medical services, while private insurance does not formally exist. 28 Funding for healthcare in Poland is principally through the health insurance system. The Polish healthcare system faces a number of challenges and in the European Health Care Index 2012 (EHIC) it was ranked 27 th out of 33 rated countries. 31 The OECD acknowledged the problems troubling Polish healthcare in a previous report, describing the system as inefficient due to poor healthcare management. Other points raised in the report are: long waiting lists for procedures; low levels of digitalization; and a disproportionately small private healthcare market. 32 The OECD suggests that the allocation and use of resources would be improved by: shifting resources from hospitals to primary and long-term care, potentially by integrated healthcare delivery models; strengthening primary medicine's gate-keeping role; providing clearer incentives to hospitals to rationalize their resource use; promoting the development of hospital management skills; and streamlining the responsibilities of the NFZ and central and local governments. 33 In 2013, the NFZ strengthened the role of outpatient specialists for some minor surgical procedures. Pilot projects testing different forms of co-ordinated care are taking place in 2014. Planned decentralization would streamline responsibilities between independent regional centres in charge of assessing health needs and investment planning, and a national authority in charge of pricing, quality control and technology assessment. In Russia, the private sector is playing an increasingly prominent role in the health system. It has developed in a rather similar way to the rest of the private services sector in Russia once the free market was introduced. Liberalization began in 1990; growth of the private medical sector thereafter was initially chaotic; then the emergence of fierce competition over the last ten years, coupled with the global economic crisis, have weeded out ineffective market participants to leave a robust and thriving private market. Private clinics are most actively developing in dentistry, urology, gynaecology and ophthalmology. 37 In some areas, though, even these niches are still not filled with a competitive market. So there is plenty of room for further development. The Russian private healthcare market is expected to maintain the current high growth rate of 12% in the near future. 38 Not that there are no obstacles to contend with, principally strict government regulation, Rising to the challenge | Siemens Financial Services | August 2014 citizens' credit profiles and a lack of qualified specialists 39 (in this respect similar to the Chinese and Turkish health sectors).
The main drivers of growth in the private sector are quality, organization, and timeliness issues in the public healthcare services. 40 In the US, healthcare is based on a developed system of private medical institutions, constituting not less than 60% of all the nation's medical facilities; by comparison, around 20% of healthcare expenditure in Russia is served by the private sector, but this proportion is growing fast. 41
In the Russian context, then, it is the private sector that is most likely to develop its take-up of asset finance to sustainably finance the medical equipment that helps institutions deliver top quality clinical services to patients, and thereby attract patient income in an increasingly competitive landscape.
SPAIN:
To improve the efficiency of medical services provision in Spain, the Health Cohesion & Quality Law (published back in 2003) aimed to guarantee a unified national health system despite devolution of autonomy in the regions. However, the economic downturn which so badly affected Spain has left the government having to outsource swathes of the health service to the private sector in a bid to cut costs, resulting in a series of 'White Tide' public demonstrations by health sector workers. 42 Spain already has one of the lowest public expenditures on healthcare in relation to its Gross Domestic Product (GDP) in the EU. National health budget cuts of over a billion euros in 2013, and parallel regional budget cuts to health and social care services coincided with increased demands on Spain's health system, particularly affecting the elderly, disabled people and those with poor mental health.
Other key changes made by the Spanish government include excluding undocumented immigrants from accessing free healthcare services and increasing the copayments that patients must make for extra treatments such as drugs, prosthetics and some ambulance trips. Authorities with devolved powers in 17 regions across Spain have also been required to make further cuts, and in Madrid and Catalonia this has led to a move towards privatization of hospitals, increases in waiting times, cutbacks in emergency services and fewer surgical procedures. 43 On top of this, the growth rate of private health insurance has slowed, increasing the burden on the state-run system. 44 All this has exacerbated a number of fundamental shortcomings in the medical device sector. Equipment replacement cycles have tended to be lengthy. And there is considerable disparity between institutions and regions. In one case, a facility will have the full spectrum of high-grade equipment and products; in another, clinicians and care staff are coping with outdated machines and shortages of basic goods. 45 Spain is a health system in crisis, facing huge financial pressures and, as a result, is anxious to access any form of finance that releases much needed funds for frontline provision. Asset finance is just one of the available financing techniques that allow Spanish institutions to optimize their working capital position to the benefit of their patients.
TURKEY:
Turkey has made some important changes in its healthcare system in the past ten years, the cornerstones being the establishment of a family physician-based system for primary health care, a mandatory health insurance fund based on payroll tax run by the Social Security Institution (SSI), and the development of state-private sector partnership for hospital management. 46 Public Private Partnership (PPP) in particular is playing a key role in the construction of huge integrated health campuses all around Turkey. The country has seen steadily decreasing infant mortality rates and steadily increasing life expectancy as the reforms have taken hold.
However, some important issues remain. Premiums collected through the SSI only support half of overall health spending, resulting in an increase in co-payments and additional health insurance policies. In addition, elements of healthcare in Turkey are being privatized. This is noted to have particular advantages, such as effective and timely implementation of new technologies and better quality healthcare, in addition to decreasing the burden on the general budget; but healthcare access for the disadvantaged sections of society still remains a challenge. 47 Cost is a concern too. Rising to the challenge | Siemens Financial Services | August 2014
Furthermore, an abiding additional challenge for the Turkish healthcare system is a skills shortage as the health infrastructure rapidly develops.
Given that Turkish base rates recently underwent a massive rise (an issue for private health sector borrowing costs), and given the sheer pace of development in the Turkish healthcare infrastructure, the attraction of asset finance packages that might bundle equipment, maintenance, service and set-up period together, is very strong. Single, tailored arrangements such as this provide a clear, reliable and transparent financing method which helps to manage the financial outlay and avoid hidden cost escalation.
UNITED KINGDOM: Everyone in the UK healthcare sector is highly aware of the 2015 Nicolson target of £20 billion in 'efficiency savings' (doing more with the same resources) and, as the country fast approaches the deadline it is apparent that there is ground to make up. The National Health Service (NHS) is reported to be behind on efficiency savings, 49 and a survey of NHS Finance Directors last year by the Kings Fund 50 predicts that the NHS will not meet the 2015 targets. Even as the strain is telling on the health service in the short term, few are remembering that 2015 will then be followed by a stretch target of £50 billion in efficiency savings by 2020.
Even as the financial efficiency pressure mounts, the recent structural changes to the NHS are imposing other anxieties on Acute Trusts. 51 Clinical Commissioning Groups ('CCGs' -made up of groups of primary care doctors) are now responsible for planning buying services for their patient community. The ability of patients, and their general practitioners, to make an objective choice about where, and by whom, the patient will be best treated, has been further enhanced by an initiative from the Royal College of Surgeons which resulted in 3,500 surgeons publishing the outcomes of their operations.
This makes the impact of 'funds following the patient' a much clearer and more present concern for Acute Trust planners and financial managers. Even while the operating cost squeeze is on, Trusts need to maintain standards of excellence, and be in a position to offer the latest technological capabilities, in order to keep a high commissioning level from the CCGs, who will be concerned to offer their patients the best available health services.
The desire to outsource some Acute Trust services and the impetus to move some care provision away from large facilities and into the community appears to be manifesting itself in genuine opportunities, and there is a consensus 49 In the free market in healthcare provision found in the US, the need to invest in up-to-date medical technology is mainly as a competitive differentiator between healthcare providers. Recently the competition has become much greater due to a number of different factors.
The Affordable Care Act aims to expand access to insurance to over 30 million Americans (most of whom were previously uninsured) and increase insurance coverage of pre-existing condition. The Act has already expanded coverage of young adults by allowing them to stay on their parents' plans until the age of 26. It has also made it illegal to impose lifetime limits on what a health insurance policy will cover. The cost of drugs for seniors on Medicare has been reduced, enabling around 12 million people to get premium rebates totaling over a billion dollars. And access to free preventive care has been extended for all patients. 54 2014 sees the Act introduce mandatory cover -in other words, insurers must offer cover to everyone, and there will be financial and legal penalties for any individual who remains uninsured. Commentators concur that all this will drive down reimbursement rates for treatments. Rising to the challenge | Siemens Financial Services | August 2014 light of the reductions in private and government insurance reimbursement rates.
The combination of these important market dynamics has increased the competitive pressure between US healthcare providers in the battle to win customers/patients. It is also arguable that such competitive pressures are also driving greater efficiency in the US healthcare sector. Hospitals in the United States have turned up the volume of their advertising and marketing, often using their powerful, upto-date medical technology facilities as a key attractor for would-be patients. This recent growth in healthcare advertising is widely corroborated, 55 and has provoked major debate about the proportion of budget that should be devoted to acquiring new patients, and furthermore, whether there should be geographical restrictionsstopping more remote healthcare providers encroaching on the natural catchment of a more local provider.
The combination of downward pressure on reimbursement rates, along with increasing competition for patients, means that hospitals are looking to optimize all their sources of finance, and asset financing techniques present another vital and attractive source of funds.
The Size of the Financial Challenge and the Role of Asset Finance
Finally, in order to give an idea of the scale of the challenge posed by medical equipment acquisition in each of the countries studied in this paper, the figures in the table on the following page offer readers the projected capital cost of equipment acquisition in the health sector over the next three years (2014-16 inclusive) . This figure is then expressed as a proportion of GDP in order to view its significance in the light of each national economy. Finally, so that the percentage of GDP represented by medical equipment acquisition is given extra perspective, total healthcare expenditure is also expressed as a percentage of GDP (using the latest published figures -2011).
In Europe, the significant financial strain under which the global healthcare system is being put will inevitably impair At the same time, some of the capital that is made available is often in the form of last-minute annual surpluses, which has to be spent before the year closes (in public healthcare systems such as the UK). This produces distortions in planning and is not conducive to careful and sustainable equipment investments. Previous studies from SFS have highlighted the volumes of capital in Europe and Asia that are currently 'frozen' in outright medical equipment purchase, which could be freed for frontline service through the use of asset finance and leasing. 56 The creation of financially sustainable healthcare systems is therefore imperative. As has been the case for a long time in the US, methods of accessing private capital are vital. Financing techniques, where monthly payments can be considered in relation to monthly patient throughput rates and quality of diagnosis and care, enable healthcare finance managers to more easily understand, allocate and calculate cost-per-treatment/diagnosis and therefore manage costs more closely, accurately and effectively. This explains why forward thinking finance managers are increasingly using asset financing techniques for medical equipment, including leasing and renting, to match cash flows with diagnosis/treatment advances, as well as operational/clinical efficiencies.
Evidence, from SFS-commissioned research 57 and from third party research sources, indicates that annual growth rates for medical equipment leasing and renting is outpacing growth in the healthcare equipment market as a whole. The natural conclusion from this data is that a steadily increasing proportion of healthcare equipment is being acquired through an efficient financing plan, in the form of leasing or renting. 
